P85.05 MET Exon 14 Skipping Mutation Positive Non-Small Cell Lung Cancer: A Population-Based Cohort

I. Bosdet , A. Karsan , C. Hughesman , C. Ho
Journal of Thoracic Oncology 16 ( 3)

2021
PS2 - 167 CIC Deficiency is Associated with Dysregulation of Genes Involved in Cell Adhesion and Developmental Processes

V.G. LeBlanc , S. Chittaranjan , M. Firme , S.Y. Chan
Canadian Journal of Neurological Sciences 43

2016
Precision Care of Brain Tumour Patients via Personalized OncoGenomics – Promises and Challenges

S. Yip , M.A. Marra
Canadian Journal of Neurological Sciences 42

2015
MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

E. R. Gerstner , S. Yip , D. L. Wang , D. N. Louis
Neurology 73 ( 18) 1509 -1510

83
2009
At the Interface of the Immune System and the Nervous System: How Neuroinflammation Modulates the Fate of Neural Progenitors In Vivo

F. -J. Mueller , S. R. McKercher , J. Imitola , J. F. Loring
Opportunities and Challenges of the Therapies Targeting CNS Regeneration ( 53) 83 -114

18
2005
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study.

B.S. Sheffield , B. Tessier-Cloutier , H. Li-Chang , Y. Shen
Current Oncology 23 ( 6) 571 -575

6
2016
A Canadian guideline on the use of next-generation sequencing in oncology.

S. Yip , A. Christofides , S. Banerji , M. R. Downes
Current Oncology 26 ( 2) 241 -254

12
2019
Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact.

K.M. Johnston , B.S. Sheffield , S. Yip , P. Lakzadeh
Current Oncology 27 ( 6) 569 -577

12
2020
Implementation of the 2016 WHO CNS Classification for infiltrating glioma: the VGH experience

A.B. Levine , S. Yip
Canadian Journal of Neurological Sciences 45

2018
29 Unraveling molecular drivers of brain cancers at the clinical setting

D. Wong , Y. Shen , A. B. Levine , T. Hoon Lee
Canadian Journal of Neurological Sciences 45

2018
Investigations of the functional interactions between CIC and ATXN1L in Oligodendroglioma

D. Wong , V. Leblanc , S. Chittaranjan , M. Marra
Canadian Journal of Neurological Sciences 44

1
2017
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer.

M.A. Marra , J. Laskin , H.J. Lim , M.R. Jones
Annals of Oncology 27 ( 5) 801 -806

32
2016
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer

M.R. Jones , H. Lim , Y. Shen , E. Pleasance
Annals of Oncology 28 ( 12) 3092 -3097

46
2017
OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor

P. K. Brastianos , C. Alvarez-Breckenridge , J. J. Miller , N. Nayyar
Neuro-oncology 19

1
2017
P1.01-40 EGFR ctDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease

A. Pender , C. Hughesman , E. Law , A. Kristanti
Journal of Thoracic Oncology 14 ( 10)

2019